Summit Therapeutics Plc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Summit Therapeutics Plc
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Summit Therapeutics Plc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Summit Therapeutics Plc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Summit Therapeutics Plc is SMMT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Summit Therapeutics Plc has its primary listing on NASDAQ. You can trade Summit Therapeutics Plc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Summit Therapeutics Plc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Summit Therapeutics Plc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Summit Therapeutics Plc.